By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ampio Pharmaceuticals, Inc. 

5445 DTC Parkway, P4

Greenwood Village  Colorado  80111  U.S.A.
Phone: 303-418-1000 Fax: 303-418-1001


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ampio Pharmaceuticals, Inc. (AMPE) Hosts Investor Call To Discuss Updates On Ampion And Optina 7/20/2015 11:52:51 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Thursday, July 16, 4:30 p.m. EDT 7/9/2015 11:40:41 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Additional Statistically Significant Study Results For Optina In The Treatment Of Diabetic Macular Edema (DME) 6/22/2015 6:55:55 AM
Ampio Pharmaceuticals, Inc. (AMPE) Provides Information On The Formation And Significance Of Aytu Bioscience To Ampio Shareholders 6/16/2015 9:39:59 AM
Ampio Pharmaceuticals, Inc. (AMPE) Reports The Synergistic Effects Of Ampion In The Treatment Of Osteoarthritis Of The Knee In Three Peer-Reviewed Publications 6/9/2015 6:52:07 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Update Of STRIDE Study For The Investigation Of Pain Associated With Osteoarthritis 6/4/2015 6:48:24 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Positive Study Results On Optina For The Treatment Of Diabetic Macular Edema 5/21/2015 8:32:21 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Thursday, April 23, 4:30 p.m. ET 4/22/2015 3:13:59 PM
Ampio Pharmaceuticals, Inc. (AMPE) Shares Decimated on Failed Trial Results 4/20/2015 11:32:42 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Top-Line Results Of The Double-Blind Multiple Intra-Articular Injections (STRUT) Study Of Ampion In Patients With Moderate To Severe Osteoarthritis Of The Knee 2/25/2015 6:06:52 AM
12345678910...
//-->